Search
Taysha Gene Therapies Inc
TSHAAdd to Watchlist
6.650USD
-0.160-2.35%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.13BMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-01 The current financial score of Taysha Gene Therapies Inc is 7.60, ranking 106 out of 387 in the Biotechnology & Medical Research industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 0.00, representing a year-over-year decrease of 100.00%, while its net profit experienced a year-over-year decrease of 96.99%.
Financials
9.21
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.21
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
3.07
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.50
Free cash flow
Relevant data have not been disclosed by the company yet.